Hola Terreta, hola, Valencia! We hope you’re having an excellent start of the week!

"En el núcleo del DeepTech, florece la innovación que redefine nuestro mundo. Es el punto donde la ciencia se une con el coraje para enfrentar los mayores retos de la humanidad. Construyamos juntos el futuro, transformando posibilidades en realidades, un descubrimiento a la vez."

"At the heart of DeepTech, innovation thrives to redefine our world. It is where science meets courage to tackle humanity's greatest challenges. Together, let’s build the future, turning possibilities into realities, one discovery at a time."

The largest Startup and Deeptech companies newsletter in the world (+300 cities)

This Newsletter is brought to you by DeepTech Builder

Turning science into world-changing companies. They speak both worlds—academic and corporate—and act as the bridge that takes breakthrough DeepTech to market.

Read more 

Gut microbes may mediate the link between drinking sugary beverages and diabetes risk

It is well known that consuming sugary drinks increases the risk of diabetes, but the mechanism behind this relationship is unclear. Now, in a paper appearing in Cell Metabolism, researchers show that metabolites produced by gut microbes might play a role.

Read more

Harnessing chaos: How the brain turns randomness into robust memory

Random noise, such as background hubbub on a phone call, is usually thought of as unwanted interference. Now researchers at Columbia Engineering find the brain may harness unavoidable random fluctuations of its activity to perform useful computations, particularly in tasks relying on memory.

Read more

Europe’s startups go the last mile at CES

From AI-powered boating to brainwave biometrics, Europe’s founders are using CES’s final day to pitch practical tech with real-world impact.

Read more

Andreessen Horowitz’s $15B mega-raise eyes ‘American Dynamism’ dominance

Andreessen Horowitz has completed one of the most consequential capital raises in modern venture history, locking in more than $15 billion in fresh funding at a time when many firms are still struggling to return capital.

Read more 

Anduril-backer Lux Capital lands $1.5B for its biggest fund yet to back defence and frontier AI

At a time when venture capital fundraising in the US has slowed to a decade low, Lux Capital has gone in the opposite direction. The 25-year-old firm has closed a $1.5 billion ninth fund, the largest in its history, pushing its assets under management to $7 billion.

Read more 

Enlightra exits stealth with $15M to power energy-efficient AI data centre lasers

Enlightra targets AI’s scaling bottleneck by replacing power-intensive electrical data links with ultra-efficient optical communication, enabled by its patented multicolour comb-laser platform.

Read more

FluoSphera secures €1.23M to expand human-based preclinical platform

The Swiss healthtech startup’s patented multi-tissue platform is designed to improve the speed, safety, and human relevance of drug discovery.

Read more

ViCentra secures an additional $13M to accelerate growth and advance next-gen insulin system

ViCentra is expanding production and international operations while advancing its Kaleido insulin patch pump to support diabetes management and strengthen its position in the growing insulin delivery market.

Read more

Rosberg Ventures closes $100M Fund III as Nico Rosberg bets on long-game venture strategy

Rosberg says the fund was oversubscribed and capped for performance, as Rosberg Ventures scales its fund-of-funds and direct investment platform past $200M in assets under management.

Read more

France’s answer to Helsing: Harmattan AI secures $200M from Dassault Aviation

Europe’s defence-tech race has entered a sharper phase. Just months after Helsing announced its latest major funding round of €600 million, a fast-rising rival from France has now secured a strategic backer. Dassault Aviation has teamed up with Harmattan AI, leading the startup’s $200 million Series B funding round.

Read more